Advertisement
UK markets close in 7 hours 49 minutes

  • FTSE 100

    8,081.17
    +36.36 (+0.45%)
     

  • FTSE 250

    19,796.82
    -2.90 (-0.01%)
     

  • AIM

    756.06
    +1.19 (+0.16%)
     

  • GBP/EUR

    1.1635
    +0.0007 (+0.06%)
     

  • GBP/USD

    1.2437
    -0.0016 (-0.13%)
     

  • Bitcoin GBP

    53,708.83
    +488.44 (+0.92%)
     

  • CMC Crypto 200

    1,419.86
    -4.24 (-0.30%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    83.49
    +0.13 (+0.16%)
     

  • GOLD FUTURES

    2,335.60
    -6.50 (-0.28%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,170.89
    +341.96 (+2.03%)
     

  • DAX

    18,180.67
    +43.02 (+0.24%)
     

  • CAC 40

    8,090.68
    -15.10 (-0.19%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Revolution Medicines (RVMD) Catches Eye: Stock Jumps 10.2%

Zacks Equity Research
·2-min read

Revolution Medicines, Inc. RVMD was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $26.08 –$39.34 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Revolution Medicines currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Revolution Medicines, Inc. Price

Revolution Medicines, Inc. Price
Revolution Medicines, Inc. Price

Revolution Medicines, Inc. price | Revolution Medicines, Inc. Quote

ADVERTISEMENT

Investors interested in the Medical - Drugs industry may consider a better-ranked stock like Avenue Therapeutics Inc. ATXI, which carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Avenue Therapeutics, Inc. (ATXI) : Free Stock Analysis Report
 
Revolution Medicines, Inc. (RVMD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research